A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
about
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
A Multicenter Open-label Phase ...... sophageal Squamous Cell Cancer
@en
A Multicenter Open-label Phase ...... sophageal Squamous Cell Cancer
@nl
type
label
A Multicenter Open-label Phase ...... sophageal Squamous Cell Cancer
@en
A Multicenter Open-label Phase ...... sophageal Squamous Cell Cancer
@nl
prefLabel
A Multicenter Open-label Phase ...... sophageal Squamous Cell Cancer
@en
A Multicenter Open-label Phase ...... sophageal Squamous Cell Cancer
@nl
P1050
P3098
NCT03416244